메뉴 건너뛰기




Volumn 57, Issue 5, 2014, Pages 2136-2160

Discovery of a novel class of potent HCV NS4B inhibitors: SAR studies on piperazinone derivatives

Author keywords

[No Author keywords available]

Indexed keywords

( 3,6 ) 3,6 DIISOBUTYL 4 ((1,2) 2 PHENYLCYCLOPROPANECARBONYL)PIPERAZIN 2 ONE; (2,5) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 5 ISOBUTYL 6 OXOPIPERAZINE 2 CARBOXYLIC ACID; (3,6) 3,6 DIISOBUTYL 4 ((1,2) 2 PHENYLCYCLOPROPANECARBONYL)PIPRAZIN 2 ONE; (3,6) 3,6 DIISOBUTYLPIPERAZIN 2 ONE; (3,6) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 3 ISOBUTYL 6 (1H PYRROL 2 YL)PIPERAZIN 2 ONE; (3,6) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 3 ISOBUTYL 6 VINYLPIPERAZIN 2 ONE; (3,6) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 3 ISOBUTYL 6(OXAZOL 2 YL)PIPERAZIN 2 ONE; (3,6) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 3 ISOBUTYL 6(OXAZOL 5 YL)PIPERAZIN 2 ONE; (3,6) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 3,6 DIISOBUTYLPIPERAZIN 2 ONE; (3,6) 4 (5 (4 FLUOROPHENYL)ISOXAZOLE 3 CARBONYL) 6 (FURAN 2YL) 3 ISOBUTYLPIPERAZIN 2 ONE; AMIDE; ANTIVIRUS AGENT; CARBONYL DERIVATIVE; HETEROCYCLIC COMPOUND; ISOXAZOLE; NONSTRUCTURAL PROTEIN 4B; PIPERAZINE DERIVATIVE; THIOPHENE; UNCLASSIFIED DRUG;

EID: 84896263507     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4012643     Document Type: Article
Times cited : (49)

References (42)
  • 1
    • 74549128529 scopus 로고    scopus 로고
    • Epidemiology of hepatitis B and C viruses: A global overview
    • Te, H. S.; Jensen, D. M. Epidemiology of hepatitis B and C viruses: a global overview Clin. Liver Dis. 2010, 14, 1-21
    • (2010) Clin. Liver Dis. , vol.14 , pp. 1-21
    • Te, H.S.1    Jensen, D.M.2
  • 2
    • 23944506014 scopus 로고    scopus 로고
    • Global epidemiology of hepatitis C virus infection
    • Shepard, C. W.; Finelli, L.; Alter, M. J. Global epidemiology of hepatitis C virus infection Lancet Infect. Dis. 2005, 5, 558-567
    • (2005) Lancet Infect. Dis. , vol.5 , pp. 558-567
    • Shepard, C.W.1    Finelli, L.2    Alter, M.J.3
  • 3
    • 84860287080 scopus 로고    scopus 로고
    • Epidemiology of viral hepatitis and hepatocellular carcinoma
    • El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 2012, 142, 1264-1273
    • (2012) Gastroenterology , vol.142 , pp. 1264-1273
    • El-Serag, H.B.1
  • 4
    • 33748114343 scopus 로고    scopus 로고
    • The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
    • Perz, J. F.; Armstrong, G. L.; Farrington, L. A.; Hutin, Y. J. F.; Bell, B. P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide J. Hepatol. 2006, 45, 529-538
    • (2006) J. Hepatol. , vol.45 , pp. 529-538
    • Perz, J.F.1    Armstrong, G.L.2    Farrington, L.A.3    Hutin, Y.J.F.4    Bell, B.P.5
  • 5
    • 80755159054 scopus 로고    scopus 로고
    • Discovery and development of telaprevir: An NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus
    • Kwong, A. D.; Kauffman, R. S.; Hurter, P.; Mueller, P. Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus Nature Biotechnol. 2011, 29, 993-1003
    • (2011) Nature Biotechnol. , vol.29 , pp. 993-1003
    • Kwong, A.D.1    Kauffman, R.S.2    Hurter, P.3    Mueller, P.4
  • 6
    • 84860526352 scopus 로고    scopus 로고
    • Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections
    • Venkatraman, S. Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections Trends Pharmacol. Sci. 2012, 33, 289-294
    • (2012) Trends Pharmacol. Sci. , vol.33 , pp. 289-294
    • Venkatraman, S.1
  • 7
    • 79952907820 scopus 로고    scopus 로고
    • The journey to the discovery of boceprevir: An NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C
    • Chen, K. X.; Njoroge, F. G. The journey to the discovery of boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis C Prog. Med. Chem. 2010, 49, 1-36
    • (2010) Prog. Med. Chem. , vol.49 , pp. 1-36
    • Chen, K.X.1    Njoroge, F.G.2
  • 8
    • 84856371566 scopus 로고    scopus 로고
    • New Merck and Vertex drugs raise standard of care in hepatitis C
    • Sheridan, C. W. New Merck and Vertex drugs raise standard of care in hepatitis C Nature Biotechnol. 2011, 29, 553-554
    • (2011) Nature Biotechnol. , vol.29 , pp. 553-554
    • Sheridan, C.W.1
  • 9
    • 0037517079 scopus 로고    scopus 로고
    • Side effects of therapy for chronic hepatitis C
    • Fried, M. W.; Russo, M. W.; Fried, M. W. Side effects of therapy for chronic hepatitis C Gastroenterology 2003, 124, 1711-1719
    • (2003) Gastroenterology , vol.124 , pp. 1711-1719
    • Fried, M.W.1    Russo, M.W.2    Fried, M.W.3
  • 10
    • 33747797031 scopus 로고    scopus 로고
    • Treating viral hepatitis C: Efficacy, side effects, and complications
    • Manns, M. P.; Wedemeyer, H.; Cornberg, M. Treating viral hepatitis C: efficacy, side effects, and complications Gut 2006, 55, 1350-1359
    • (2006) Gut , vol.55 , pp. 1350-1359
    • Manns, M.P.1    Wedemeyer, H.2    Cornberg, M.3
  • 11
    • 0034484070 scopus 로고    scopus 로고
    • Genome of human hepatitis C virus (HCV): Gene organization, sequence diversity, and variation
    • Kato, N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation Microb. Comp. Genomics 2000, 5 (3) 129-151
    • (2000) Microb. Comp. Genomics , vol.5 , Issue.3 , pp. 129-151
    • Kato, N.1
  • 12
    • 34250681358 scopus 로고    scopus 로고
    • Hepatitis C virus proteins
    • Dubuisson, J. Hepatitis C virus proteins World J. Gastroenterol. 2007, 13 (17) 2406-2415
    • (2007) World J. Gastroenterol. , vol.13 , Issue.17 , pp. 2406-2415
    • Dubuisson, J.1
  • 13
    • 84855209804 scopus 로고    scopus 로고
    • Direct acting antivirals for the treatment of chronic hepatitis C: One pill a day for tomorrow
    • Asselah, T.; Marcellin, P. Direct acting antivirals for the treatment of chronic hepatitis C: One pill a day for tomorrow Liver Int. 2012, 32 (Suppl 1) 88-102
    • (2012) Liver Int. , vol.32 , Issue.SUPPL. 1 , pp. 88-102
    • Asselah, T.1    Marcellin, P.2
  • 14
    • 84860322902 scopus 로고    scopus 로고
    • New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives
    • Welsch, C.; Jesudian, A.; Zeuzem, S.; Jacobson, I. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives Gut Liver 2012, 61, i36-i46
    • (2012) Gut Liver , vol.61
    • Welsch, C.1    Jesudian, A.2    Zeuzem, S.3    Jacobson, I.4
  • 15
    • 80555127355 scopus 로고    scopus 로고
    • Drugs in development for chronic hepatitis C: A promising future
    • Pockros, P. J. Drugs in development for chronic hepatitis C: a promising future Expert Opin. Biol. Ther. 2011, 11, 1611-1622
    • (2011) Expert Opin. Biol. Ther. , vol.11 , pp. 1611-1622
    • Pockros, P.J.1
  • 16
    • 84855921173 scopus 로고    scopus 로고
    • Novel therapies for hepatitis C: Insights from the structure of the virus
    • Fusco, D. N.; Chung, R. T. Novel therapies for hepatitis C: insights from the structure of the virus Annu. Rev. Med. 2012, 63, 373-387
    • (2012) Annu. Rev. Med. , vol.63 , pp. 373-387
    • Fusco, D.N.1    Chung, R.T.2
  • 19
    • 78650021698 scopus 로고    scopus 로고
    • Recent advances in hepatitis C virus treatment: Review of HCV protease inhibitor clinical trials
    • Chary, A.; Holodniy, M. Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials Rev. Recent Clin. Trials 2010, 5, 158-173
    • (2010) Rev. Recent Clin. Trials , vol.5 , pp. 158-173
    • Chary, A.1    Holodniy, M.2
  • 20
    • 81855220325 scopus 로고    scopus 로고
    • The therapeutic approaches for hepatitis C virus: Protease inhibitors and polymerase inhibitors
    • Kwo, P. Y.; Vinayek, R. The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors Gut 2011, 5, 406-417
    • (2011) Gut , vol.5 , pp. 406-417
    • Kwo, P.Y.1    Vinayek, R.2
  • 21
    • 84952988807 scopus 로고    scopus 로고
    • Daclatasvir dihydrochloride: Treatment of hepatitis C virus HCV NS5A inhibitor
    • Reviriego, C. Daclatasvir dihydrochloride: treatment of hepatitis C virus HCV NS5A inhibitor Drugs Future 2011, 36, 735-739
    • (2011) Drugs Future , vol.36 , pp. 735-739
    • Reviriego, C.1
  • 22
    • 81855220325 scopus 로고    scopus 로고
    • The therapeutic approaches for hepatitis C virus: Protease inhibitors and polymerase inhibitors
    • Kwo, P. Y.; Vinayek, R. The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors Gut 2011, 5, 406-417
    • (2011) Gut , vol.5 , pp. 406-417
    • Kwo, P.Y.1    Vinayek, R.2
  • 23
    • 84858722318 scopus 로고    scopus 로고
    • Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase
    • Sofia, M. J.; Chang, W.; Furman, P. A.; Mosley, R. T.; Ross, B. S. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase J. Med. Chem. 2012, 55, 2481-2531
    • (2012) J. Med. Chem. , vol.55 , pp. 2481-2531
    • Sofia, M.J.1    Chang, W.2    Furman, P.A.3    Mosley, R.T.4    Ross, B.S.5
  • 24
    • 77953445361 scopus 로고    scopus 로고
    • Non-nucleoside inhibitors of hepatitis C virus polymerase: Current progress and future challenges
    • Li, H.; Shi, S. T. Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges Future Med. Chem. 2010, 2, 121-141
    • (2010) Future Med. Chem. , vol.2 , pp. 121-141
    • Li, H.1    Shi, S.T.2
  • 26
    • 77953013128 scopus 로고    scopus 로고
    • Rapid emergence of protease inhibitor resistance in hepatitis C virus
    • Rong, L.; Dahari, H.; Ribeiro, R. M.; Perelson, A. S. Rapid emergence of protease inhibitor resistance in hepatitis C virus Sci. Transl. Med. 2010, 2, 1-9
    • (2010) Sci. Transl. Med. , vol.2 , pp. 1-9
    • Rong, L.1    Dahari, H.2    Ribeiro, R.M.3    Perelson, A.S.4
  • 27
    • 84876246624 scopus 로고    scopus 로고
    • Persistence of variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir
    • Wang, C.; Sun, J. H.; O'Boyle, D. R.; Nower, P.; Valera, L.; Roberts, S.; Fridell, R. A.; Gao, M. Persistence of variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir Antimicrob. Agents Chemother. 2013, 57 (5) 2054-2065
    • (2013) Antimicrob. Agents Chemother. , vol.57 , Issue.5 , pp. 2054-2065
    • Wang, C.1    Sun, J.H.2    O'Boyle, D.R.3    Nower, P.4    Valera, L.5    Roberts, S.6    Fridell, R.A.7    Gao, M.8
  • 28
    • 83555174694 scopus 로고    scopus 로고
    • In vitro selection and characterization of HCV replicons resistent to multiple non-nucleoside polymerase inhibitors
    • Delang, L.; Vliegen, I.; Leyssen, P.; Neyts, J. In vitro selection and characterization of HCV replicons resistent to multiple non-nucleoside polymerase inhibitors J. Hepatol. 2012, 56 (1) 41-48
    • (2012) J. Hepatol. , vol.56 , Issue.1 , pp. 41-48
    • Delang, L.1    Vliegen, I.2    Leyssen, P.3    Neyts, J.4
  • 29
    • 77649175920 scopus 로고    scopus 로고
    • Hepatitis C virus nonstructural protein 4B: A journey into unexplored territory
    • Gouttenoire, J.; Roingeard, P.; Penin, F.; Moradpour, D. Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory Rev. Med. Virol. 2010, 20 (2) 117-129
    • (2010) Rev. Med. Virol. , vol.20 , Issue.2 , pp. 117-129
    • Gouttenoire, J.1    Roingeard, P.2    Penin, F.3    Moradpour, D.4
  • 30
    • 80054117912 scopus 로고    scopus 로고
    • Hepatitis C virus - Progress towards inhibiting the nonenzymatic viral proteins
    • Meanwell, N. A.; Belema, M. Hepatitis C virus-Progress towards inhibiting the nonenzymatic viral proteins Annu. Rep. Med. Chem. 2011, 46, 268-270
    • (2011) Annu. Rep. Med. Chem. , vol.46 , pp. 268-270
    • Meanwell, N.A.1    Belema, M.2
  • 37
    • 0010658836 scopus 로고
    • Synthese von 3,6-disubstituierten 2-oxopiperazinen
    • Masaki, V. M.; Ohta, M. Synthese von 3,6-disubstituierten 2-oxopiperazinen Bull. Chem. Soc. Jpn. 1963, 36 (8) 922-925
    • (1963) Bull. Chem. Soc. Jpn. , vol.36 , Issue.8 , pp. 922-925
    • Masaki, V.M.1    Ohta, M.2
  • 38
    • 0030840273 scopus 로고    scopus 로고
    • A new synthesis of α-arylglycines from aryl boronic acids
    • Petasis, N. A.; Goodman, A.; Zavialov, T. A new synthesis of α-arylglycines from aryl boronic acids Tetrahedron 1997, 53 (48) 16463-16470
    • (1997) Tetrahedron , vol.53 , Issue.48 , pp. 16463-16470
    • Petasis, N.A.1    Goodman, A.2    Zavialov, T.3
  • 39
    • 77951002240 scopus 로고    scopus 로고
    • A straightforward three-component synthesis of α-amino esters containing a phenylalanine or a phenylglycine scaffold
    • Haurena, C.; Le Gall, E.; Sengmany, S.; Martens, T.; Troupel, M. A straightforward three-component synthesis of α-amino esters containing a phenylalanine or a phenylglycine scaffold J. Org. Chem. 2010, 75 (8) 2645-2650
    • (2010) J. Org. Chem. , vol.75 , Issue.8 , pp. 2645-2650
    • Haurena, C.1    Le Gall, E.2    Sengmany, S.3    Martens, T.4    Troupel, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.